News

May 18, 2021

Foundation Fournier-Majoie

A promising new project in targeted cancer therapies

The Foundation Fournier-Majoie is contributing € 500,000 to the Mablink Bioscience project to build a new generation of ADCs, a class of drugs targeted against cancer (FR)

Read more
March 25, 2021

Science

Liquid biopsies for cutting-edge cancer medicine

The detection and characterization of circulating tumor DNA must be used in clinical practice, allowing accurate follow-up of cancer patients (FR)

Read the article
March 16, 2021

Science

Biomarkers clinical implications in colorectal metastatic cancer

How biomarkers could be used to improve personalised treatment regiments of metastatic colorectal cancer patients (mCRC) (NL)

Read the article
March 2, 2021

Laureates

DNAlytics wins the Digital Wallonia 4 Good Startup Award

Our 2017 laureate, a spinoff from UCLouvain, has been rewarded for its reactivity and solutions provided to the FPS Health in the context of the Covid-19 pandemic (FR)

Read the article
February 18, 2021

Science

Pesticides: meta-analysis points to responsibility for some blood cancers

Pesticide use has been correlated with acute myeloid leukemia (FR)

Read the article
February 17, 2021

Science

Colorectal cancer screening: “Don’t postpone your examination”

Colorectal cancer is the second leading cause of cancer death in Belgium. It is urgent for the over-50s to be screened, despite the Covid-19 pandemic (FR)

Read the article
January 24, 2021

Laureates

Plants to produce a new anti-cancer molecule

ATB Therapeutics (our 2017 laureat) has developed a platform capable of generating innovative molecules from plants to fight cancer. A promising fundraising (FR)

Read the article
January 21, 2021

Science

Artificial Intelligence produces specific, optimized CAR-T cells to target cancer cells in patients

AI technology is being used to produce highly potent and optimally adapted CAR-T cell products that target the altered cells in the patient's blood or the tumor (EN)

Read the article
January 12, 2021

Science

Sanofi prepares the future in auto-immune diseases and cancer

By acquiring Kymab, Sanofi is opening up a new research and development axis in the field of monoclonal antibodies (proteins protecting our bodies from foreign substances)

Read the article
January 11, 2021

Laureates

Precirix appoints Dr. Niva Almaula as Chief Business Officer

Precirix, a private biotech that clinically tests radiopharmaceuticals in oncology, announces the arrival of Dr. Niva Almaula who will lead the company's global development strategy

Read the article